| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/24/2005 | WO2005011655A3 Pyridazine derivatives and their use as therapeutic agents |
| 03/24/2005 | WO2005004789A3 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 03/24/2005 | WO2004113519A3 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases |
| 03/24/2005 | WO2004110379A3 A1 adenosine receptor antagonists |
| 03/24/2005 | WO2004082702A8 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 03/24/2005 | WO2004039795A3 Amide compounds for the treatment of hyperlipidemia |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065205 Administering protein kinase C activator such as macrocyclic lactone; mixture with enzyme inhibitor and carrier |
| 03/24/2005 | US20050065202 Controlling appetites; dietetics; obesity; eating disorders; cachexia; antidiabetic agents |
| 03/24/2005 | US20050065196 Azole compound and medicinal use thereof |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065190 Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| 03/24/2005 | US20050065186 Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/24/2005 | US20050065180 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a growth hormone secretagogue |
| 03/24/2005 | US20050065179 Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/24/2005 | US20050065157 Carbazole derivatives and their use as npy5 receptor antagonists |
| 03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065143 Pyridazine derivatives and their use as therapeutic agents |
| 03/24/2005 | US20050065142 Antidiabetic agents; therapy for insulin resistance |
| 03/24/2005 | US20050065140 Antidepressant; side effect reduction |
| 03/24/2005 | US20050065139 Antidiabetic agents; controlling carbohydrate metabolism |
| 03/24/2005 | US20050065133 Synergistic mixture; bone disorders; osteoporosis ; anticancer agents; obesity |
| 03/24/2005 | US20050065132 Bone disorders |
| 03/24/2005 | US20050065130 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a cyclooxgenase-2 inhibitor |
| 03/24/2005 | US20050065129 Muscular disorders |
| 03/24/2005 | US20050065128 Glandular disorders |
| 03/24/2005 | US20050065126 Synergistic mixture; osteoporosis therapy; bone disorders; anticancer agents; obesity |
| 03/24/2005 | US20050065125 2-alkylidene-19-nor-vitamin D derivatives for the treatment of osteopenia or male osteoporosis |
| 03/24/2005 | US20050065121 Using probucol ester |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050065117 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bisphosphonate |
| 03/24/2005 | US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/24/2005 | US20050065108 Antidiabetic agents; antilipemic agents |
| 03/24/2005 | US20050065098 Antidiabetic agents; hypoglycemic agents; dietetics; bioavailability |
| 03/24/2005 | US20050065088 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hormone |
| 03/24/2005 | US20050065087 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and a bone morphogenetic protein |
| 03/24/2005 | US20050065085 Tissue disorders in response to injuries with administering polypeptidesand antibodies with gene delivery for inflammation such as arthritis |
| 03/24/2005 | US20050065079 Therapy for metabolism disorders ; obesity; antilipemic agents; atherosclerosis; hypotensive agents; antidiabetic agents |
| 03/24/2005 | US20050065074 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 03/24/2005 | US20050065068 Methods and compositions for reducing serum phosphate levels |
| 03/24/2005 | US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells |
| 03/24/2005 | US20050064542 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals |
| 03/24/2005 | US20050064534 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064049 Lipolysis stimulator |
| 03/24/2005 | US20050064014 Use of cystathionine |
| 03/24/2005 | US20050063992 administering to a patient 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 and an estrogen, or a salt or prodrug for treating senile osteoporosis, postmenopausal osteoporosis, bone fracture, bone graft, breast cancer, prostate cancer, obesity, osteopenia, muscle damage or sarcopenia |
| 03/24/2005 | US20050063991 administrating. to a diabetic or arteriosclerosis patient an effective amount of crude Dunaliella powder containing an approximately 1:1 ratio of all-trans and 9-cis beta -carotene |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | DE10339549A1 New glucopyranosyloxy-pyrazole derivatives are sodium dependent glucose cotransporter inhibitors used for treating and preventing metabolic disorders, particularly diabetes |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2539380A1 Method for producing insulin from a natural source and insulin |
| 03/24/2005 | CA2539158A1 Crystalline forms of ['r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid |
| 03/24/2005 | CA2539132A1 Methods for identifying modulators of protein kinase c-epsilon (pkc.epsilon.) and method of treatment of aberrant glucose metabolism associated therewith |
| 03/24/2005 | CA2538425A1 Crystals of a heterocyclic compound |
| 03/24/2005 | CA2538415A1 Use of antagonists of hepatic sympathetic nerve activity |
| 03/24/2005 | CA2538333A1 Multi-system therapy for diabetes, the metabolic syndrome and obesity comprising a hypoglycemic agent |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction |
| 03/23/2005 | EP1516866A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 03/23/2005 | EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 03/23/2005 | EP1516617A2 Use of a thiazolidinedione for reducing apoptosis of pancreatic beta cells |
| 03/23/2005 | EP1516542A1 Nutritional supplement to treat macular degeneration |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1516047A1 Purified pkb ser 473 kinase and uses thereof |
| 03/23/2005 | EP1515984A1 Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 03/23/2005 | EP1515978A1 Sulfur-containing phospholipid derivatives |
| 03/23/2005 | EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/23/2005 | EP1515972A1 Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515953A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 03/23/2005 | EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 03/23/2005 | EP1515926A2 Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia |
| 03/23/2005 | EP1515749A1 Combined use of a modulator of cd3 and a glp-1 compound |
| 03/23/2005 | EP1515746A2 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity |
| 03/23/2005 | EP1515741A1 Composition comprising viscous fibers and viscosity-lowering proteins |
| 03/23/2005 | EP1515721A1 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1515718A2 Modulation of activation of glucocorticoid receptors by breakdown products of glucocorticoids |
| 03/23/2005 | EP1515717A1 Calcium salts of indole derived statins |
| 03/23/2005 | EP1515716A2 Indole derivatives having anti-angiogenetic activity |
| 03/23/2005 | EP1515708A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 03/23/2005 | EP1515615A1 Nutritional composition for detoxification and cancer prevention |
| 03/23/2005 | EP1421182A4 Methods of inducing differentiation of stem cells |
| 03/23/2005 | EP1100469B1 Rapidly disintegrable solid preparation |
| 03/23/2005 | EP1045832B1 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 03/23/2005 | CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/23/2005 | CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists |
| 03/23/2005 | CN1599731A Benzothiazepine derivatives |
| 03/23/2005 | CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 03/23/2005 | CN1599726A Pyrimidine compounds |
| 03/23/2005 | CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 03/23/2005 | CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 03/23/2005 | CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha |